Literature DB >> 8948609

Patterns of facial nerve synkinesis.

C J Moran1, J G Neely.   

Abstract

Facial nerve synkinesis is an extremely distressing sequela of facial paralysis, and its prevention and treatment are less than adequate. Improved therapeutic interventions await better understanding of its pathogenesis. In this study, 11 patients with synkinesis and 11 normal control subjects were quantitatively assessed using a new computer-assisted, motion-sensitive system. Two additional, informative cases presenting at the completion of the study are also briefly reported. The observed synkinetic patterns appear predictable and nonrandom. In addition, these observations tend to raise doubts that the aberrant fiber regeneration hypothesis is the sole explanation of synkinesis. They further implicate facial nuclear hyperexcitability as an explanation in at least some cases of synkinesis. Understanding these patterns enhances clinical detection and evaluation and may lead to a better knowledge of the fundamental pathophysiology of synkinesis and its prevention.

Entities:  

Mesh:

Year:  1996        PMID: 8948609     DOI: 10.1097/00005537-199612000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

1.  Non-invasive stimulation of the vibrissal pad improves recovery of whisking function after simultaneous lesion of the facial and infraorbital nerves in rats.

Authors:  H Bendella; S P Pavlov; M Grosheva; A Irintchev; S K Angelova; D Merkel; N Sinis; K Kaidoglou; E Skouras; S A Dunlop; Doychin N Angelov
Journal:  Exp Brain Res       Date:  2011-04-28       Impact factor: 1.972

2.  Oculo-Auricular Synkinesia Post Bell's Palsy Causing Unilateral Wilson's Phenomenon.

Authors:  Douglas E Hobson; Andrew E Borys
Journal:  Mov Disord Clin Pract       Date:  2020-06-04

3.  Objective assessment of the reliability of the House-Brackmann and Fisch grading of synkinesis.

Authors:  Verena Meier-Gallati; Henning Scriba
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-14       Impact factor: 2.503

4.  A Novel Long-term Therapy of Facial Synkinesis with Botulinum Neurotoxins Type A and Fillers.

Authors:  Adam Wiener; Khasha Touloei; Bradley P Glick
Journal:  J Clin Aesthet Dermatol       Date:  2011-03

5.  Effective connectivity decreases in specific brain networks with postparalysis facial synkinesis: a dynamic causal modeling study.

Authors:  Zhen-Zhen Ma; Ye-Chen Lu; Jia-Jia Wu; Xu-Yun Hua; Si-Si Li; Wei Ding; Jian-Guang Xu
Journal:  Brain Imaging Behav       Date:  2021-09-22       Impact factor: 3.978

6.  Patterns of cortical reorganization in facial synkinesis: a task functional magnetic resonance imaging study.

Authors:  Yin Wang; Wei-Wei Wang; Xu-Yun Hua; Han-Qiu Liu; Wei Ding
Journal:  Neural Regen Res       Date:  2018-09       Impact factor: 5.135

7.  Motor Control Deficits in Facial Synkinesis Patients: Neuroimaging Evidences of Cerebral Cortex Involvement.

Authors:  Jia-Jia Wu; Ye-Chen Lu; Mou-Xiong Zheng; Xu-Yun Hua; Jian-Guang Xu; Wei Ding; Chun-Lei Shan
Journal:  Neural Plast       Date:  2019-03-27       Impact factor: 3.599

8.  Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.

Authors:  Justin R Shinn; Nkechi N Nwabueze; Liping Du; Priyesh N Patel; Kevin K Motamedi; Cathey Norton; William R Ries; Scott J Stephan
Journal:  JAMA Facial Plast Surg       Date:  2019-05-01       Impact factor: 4.611

9.  The Contribution of Surface Electromyographic Assessment for Defining the Stage of Peripheral Facial Paralysis: Flaccid or Sequelae Stage.

Authors:  Daniele Fontes Ferreira Bernardes; Ricardo Ferreira Bento; Maria Valeria Schimidt Goffi Gomez
Journal:  Int Arch Otorhinolaryngol       Date:  2017-10-26

10.  Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.

Authors:  Priyesh N Patel; Scott R Owen; Cathey P Norton; Brandon T Emerson; Andrea B Bronaugh; William R Ries; Scott J Stephan
Journal:  JAMA Facial Plast Surg       Date:  2018-05-01       Impact factor: 4.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.